Ting‐Lei Gu

2.8k total citations · 1 hit paper
22 papers, 1.8k citations indexed

About

Ting‐Lei Gu is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Ting‐Lei Gu has authored 22 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Genetics. Recurrent topics in Ting‐Lei Gu's work include Cancer, Hypoxia, and Metabolism (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Ting‐Lei Gu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Ting‐Lei Gu collaborates with scholars based in United States, China and Italy. Ting‐Lei Gu's co-authors include Louisa Howard, Nancy A. Speck, Miguel Marín‐Padilla, Trista E. North, Qing Wang, Michael Binder, Terryl Stacy, David Sternberg, James D. Griffin and Sumin Kang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Ting‐Lei Gu

22 papers receiving 1.8k citations

Hit Papers

Cbfa2 is required for the formation of intra-aortic hemat... 1999 2026 2008 2017 1999 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ting‐Lei Gu United States 15 1.1k 426 406 355 325 22 1.8k
Kakajan Komurov United States 23 1.7k 1.5× 241 0.6× 224 0.6× 938 2.6× 603 1.9× 44 2.5k
Yijiang Shi United States 21 1.8k 1.6× 654 1.5× 175 0.4× 521 1.5× 251 0.8× 35 2.2k
Corinne Reimer United States 23 1.4k 1.3× 147 0.3× 460 1.1× 456 1.3× 441 1.4× 52 2.1k
Shannon Elf United States 20 1.8k 1.6× 722 1.7× 193 0.5× 408 1.1× 740 2.3× 33 2.6k
Lorraine Lipfert United States 18 1.2k 1.1× 652 1.5× 507 1.2× 410 1.2× 255 0.8× 20 2.4k
Mark A. Gregory United States 16 1.5k 1.3× 335 0.8× 171 0.4× 567 1.6× 360 1.1× 21 1.9k
Keith Orford United States 21 1.9k 1.7× 275 0.6× 188 0.5× 938 2.6× 446 1.4× 36 2.7k
Suzanne Schubbert United States 12 1.7k 1.5× 188 0.4× 190 0.5× 736 2.1× 223 0.7× 22 2.3k
Ting-Lei Gu United States 12 1.6k 1.4× 513 1.2× 232 0.6× 277 0.8× 714 2.2× 12 2.1k
Marion Wiesmann Switzerland 12 980 0.9× 204 0.5× 95 0.2× 477 1.3× 166 0.5× 20 1.6k

Countries citing papers authored by Ting‐Lei Gu

Since Specialization
Citations

This map shows the geographic impact of Ting‐Lei Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting‐Lei Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting‐Lei Gu more than expected).

Fields of papers citing papers by Ting‐Lei Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting‐Lei Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting‐Lei Gu. The network helps show where Ting‐Lei Gu may publish in the future.

Co-authorship network of co-authors of Ting‐Lei Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Ting‐Lei Gu. A scholar is included among the top collaborators of Ting‐Lei Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting‐Lei Gu. Ting‐Lei Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Jun, Hee‐Bum Kang, Changliang Shan, et al.. (2014). Tyr-301 Phosphorylation Inhibits Pyruvate Dehydrogenase by Blocking Substrate Binding and Promotes the Warburg Effect. Journal of Biological Chemistry. 289(38). 26533–26541. 62 indexed citations
2.
Jin, Lingtao, Dan Li, Jong Seok Lee, et al.. (2013). p90 RSK2 Mediates Antianoikis Signals by both Transcription-Dependent and -Independent Mechanisms. Molecular and Cellular Biology. 33(13). 2574–2585. 24 indexed citations
3.
Rimkunas, Victoria, Daiqiang Li, Yerong Hu, et al.. (2012). Analysis of Receptor Tyrosine Kinase ROS1-Positive Tumors in Non–Small Cell Lung Cancer: Identification of a FIG-ROS1 Fusion. Clinical Cancer Research. 18(16). 4449–4457. 225 indexed citations
4.
Ren, Hong, Zhiping Tan, Xin Zhu, et al.. (2012). Identification of Anaplastic Lymphoma Kinase as a Potential Therapeutic Target in Ovarian Cancer. Cancer Research. 72(13). 3312–3323. 92 indexed citations
5.
Peng, Hongling, et al.. (2012). [Screen of phosphopeptide specific for acute leukemia].. PubMed. 33(3). 163–8. 1 indexed citations
6.
Fan, Jun, Taro Hitosugi, Tae‐Wook Chung, et al.. (2011). Tyrosine Phosphorylation of Lactate Dehydrogenase A Is Important for NADH/NAD + Redox Homeostasis in Cancer Cells. Molecular and Cellular Biology. 31(24). 4938–4950. 188 indexed citations
7.
Gu, Ting‐Lei, Irene Dalai, Stefano Barbi, et al.. (2011). Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. PubMed. 34(2). 141–153. 64 indexed citations
8.
Kang, Sumin, Shannon Elf, Taro Hitosugi, et al.. (2010). p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells. Journal of Clinical Investigation. 120(4). 1165–1177. 128 indexed citations
9.
Selfors, Laura M., Carolyn N. Wrobel, Ting‐Lei Gu, et al.. (2010). Profiling Y561-Dependent and -Independent Substrates of CSF-1R in Epithelial Cells. PLoS ONE. 5(10). e13587–e13587. 23 indexed citations
10.
Voena, Claudia, Elena Panizza, Lucia D’Amico, et al.. (2010). Abstract LB-309: EML4-ALK signaling is required for the maintenance of neoplastic phenotype of non-small cell lung cancer cells: Novel strategy for lung cancer-tailored therapies. Cancer Research. 70(8_Supplement). LB–309. 1 indexed citations
12.
Carretero, Julián, Takeshi Shimamura, Klarisa Rikova, et al.. (2009). Abstract B103: Integrative genomic and proteomic analyses identify novel targets for Lkb1 deficient metastatic lung tumors. Molecular Cancer Therapeutics. 8(12_Supplement). B103–B103. 4 indexed citations
13.
Tam, Winnie F., Ting‐Lei Gu, Jing Chen, et al.. (2008). Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cells. Blood. 112(5). 1981–1992. 38 indexed citations
14.
Kang, Sumin, Shannon Elf, Shaozhong Dong, et al.. (2008). FGFR3 Associates with and Tyrosine-Phosphorylates p90RSK2, Leading to RSK2 Activation That Mediates Hematopoietic Transformation. Blood. 112(11). 3722–3722. 2 indexed citations
15.
Dong, Shaozhong, Sumin Kang, Ting‐Lei Gu, et al.. (2007). 14–3-3 integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1–transformed hematopoietic cells. Blood. 110(1). 360–369. 50 indexed citations
16.
Kang, Sumin, Shaozhong Dong, Ailan Guo, et al.. (2007). Epidermal Growth Factor Stimulates RSK2 Activation through Activation of the MEK/ERK Pathway and Src-dependent Tyrosine Phosphorylation of RSK2 at Tyr-529. Journal of Biological Chemistry. 283(8). 4652–4657. 32 indexed citations
17.
Kang, Sumin, Shaozhong Dong, Ting‐Lei Gu, et al.. (2006). FGFR3 Activates RSK2 To Mediate Hematopoietic Transformation through Both Tyrosine Phosphorylation of RSK2 and Activation of the MEK/ERK Pathway.. Blood. 108(11). 514–514. 2 indexed citations
19.
Gu, Ting‐Lei, Zuzana Tóthová, Blanca Scheijen, et al.. (2004). NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a. Blood. 103(12). 4622–4629. 75 indexed citations
20.
North, Trista E., Ting‐Lei Gu, Terryl Stacy, et al.. (1999). Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development. 126(11). 2563–2575. 537 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026